Such a macroscopic and significant sign of pathology may plausibly result from molecular changes that occur as early as week 8, as indicated by up-regulated mRNA expression of cardiac hypertrophy markers like β-myosin heavy chain and VEGF. This evidence concerns the gene VEGFA and cardiac hypertrophy.